• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    GeneThera Inc. (GTHR)

    -Other OTC
    0.02 0.00(0.00%) Jan 27, 10:00AM EST
    Add to Portfolio
    ProfileGet Profile for:
    GeneThera Inc.
    7577 West 103rd Avenue
    Suite 212
    Westminster, CO 80021
    United States - Map
    Phone: 303-439-2085
    Website: http://www.genethera.net

    Index Membership:N/A
    Full Time Employees:2

    Business Summary 

    GeneThera, Inc., a biotechnology company, develops molecular diagnostic tests, therapeutics, and vaccines to control emerging diseases in animals and humans. The company develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. It is developing specific assays for chronic wasting disease (CWD) among elk and deer, and mad cow disease among cattle; and diagnostics for E. coli in cattle; and Johne's disease in dairy cattle and bison. The company’s molecular diagnostic assays solutions use real time fluorogenic polymerase chain reaction technology to detect the presence of infectious disease from the blood of live animals. In addition, the company focuses on developing therapeutic vaccines using RNA interference technology. The company’s products include Herd Guard, a Johne’s management solution; HerdCheck, a diagnostic product; HerdSafe, a purification and recombinant based DNA vaccine; and HerdSoft, a Web-based Johne’s disease management solution. Further, it offers research and development services, including molecular biology, gene therapy testing, replication-competent viral vector testing, complete somatic cell and viral vector packaging and producer cell line characterization, vector stock characterization, and vector purification process validation services, as well as custom bio-safety testing programs for somatic cell, Ex vivo cell, and tissue therapies. GeneThera, Inc. founded in 1995 and is based in Westminster, Colorado.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GeneThera Inc.

    Key Executives 
    Dr. Antonio Milici M.D., Ph.D., 60
    Founder, Chairman, Chief Exec. Officer, Pres, Chief Scientific Officer and Member of Audit Committee
    Ms. Tannya L. Irizarry , 55
    Chief Admin. Officer, Interim Chief Financial Officer, Interim Principal Accounting Officer and Sec.
    Mr. Jose R. Sandoval , 40
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders